|
Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
05/04/2026
|
|
|
Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million
05/04/2026
|
|
|
Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time
05/01/2026
|
|
|
Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
04/30/2026
|
|
|
Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
04/30/2026
|
|
|
Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System
04/24/2026
|
|
|
First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear
03/14/2026
|
|
|
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
03/02/2026
|
|
|
Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365
02/19/2026
|
|
|
Senseonics Receives European Approval for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor
01/29/2026
|
|